Sunday, November 22,  1:05 pm

Forward-looking intelligence allows you time to act. View this video on our restructuring content to see how you can benefit from our expertise.

Chicago buyout shop GTCR Golder Rauner LLC announced Monday that it has formed Actient Pharmaceuticals LLC, a $200 million acquisition platform geared at pharmaceutical companies.

The firm has hired Ed Fiorentino, formerly of Abbott Park, Ill., healthcare products maker Abbott Laboratories, as CEO.

This is a free preview of the content available in The Deal Pipeline. Subscribers enjoy access to the full story, as well as second-to-none research tools.

To request a demo, or, if you are an existing user to The Deal Pipeline, log in to your account, please scroll down and click the button.

Dig deeper, with Pipeline.

• 626 articles related to GTCR Golder Rauner LLC
• 574 company pages related to Pharmaceuticals
• 361 articles related to Abbott Laboratories
• 10 in-depth reports of PE deals in the Healthcare sector
• 10 years of news and analysis archives from the voice of The Deal Economy
  

Most searched keywords

• Deutsche Bank
• Birds Eye
• Cadbury AG
  
• Agrium Inc.
• Skadden Arps
• Revolution Money
• Tandberg ASA
• Aisling Capital
  
• Ken Lewis
  
• Natco